High-throughput neutralization measurements correlate strongly with evolutionary success of human influenza strains
eLife · 2026
DOI: 10.7554/elife.106811 ↗Kurz gefasst
Fachartikel in der Zeitschrift eLife, 2026. Verfasst von Caroline Kikawa und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Basic Sciences and Computational Biology Program, Fred Hutch Cancer Center, Seattle, United States. Hauptthemen laut MEDLINE: Influenza A Virus, H3N2 Subtype, Influenza, Human, Antibodies, Viral, Evolution, Molecular. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 111 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases, Howard Hughes Medical Institute.
Abstract (Originalsprache)
Human influenza viruses rapidly acquire mutations in their hemagglutinin (HA) protein that erode neutralization by antibodies from prior exposures. Here, we use a sequencing-based assay to measure neutralization titers for 78 recent H3N2 HA strains against a large set of children and adult sera, measuring ~10,000 total titers. There is substantial person-to-person heterogeneity in the titers against different viral strains, both within and across age cohorts. The growth rates of H3N2 strains in the human population in 2023 are highly correlated with the fraction of sera with low titers against each strain. Notably, strain growth rates are less correlated with neutralization titers against pools of human sera, demonstrating the importance of population heterogeneity in shaping viral evolution. Overall, these results suggest that high-throughput neutralization measurements of human sera against many different viral strains can help explain the evolution of human influenza.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Basic Sciences and Computational Biology Program, Fred Hutch Cancer Center, Seattle, United States.
- Department of Genome Sciences, University of Washington, Seattle, United States.
- Medical Scientist Training Program, University of Washington, Seattle, United States.
- Howard Hughes Medical Institute, Seattle, United States.
- Vaccine and Infectious Disease Division, Fred Hutch Cancer Center, Seattle, United States.
- Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, United States.
ORCID-Profile: Caroline Kikawa, John Huddleston, Janet A Englund, Trevor Bedford, Jesse D Bloom
Förderung
- NIAID NIH HHS
- National Institute of Allergy and Infectious Diseases
- Howard Hughes Medical Institute
Zitieren
APA
Kikawa, C., Loes, A. N., Huddleston, J., Figgins, M. D., Steinberg, P., Griffiths, T., Drapeau, E. M., Peck, H., Barr, I., Englund, J. A., Hensley, S. E., Bedford, T., & Bloom, J. D. (2026). High-throughput neutralization measurements correlate strongly with evolutionary success of human influenza strains. eLife. https://doi.org/10.7554/elife.106811
Vancouver
Kikawa C, Loes AN, Huddleston J, Figgins MD, Steinberg P, Griffiths T, et al. High-throughput neutralization measurements correlate strongly with evolutionary success of human influenza strains. eLife. 2026. doi:10.7554/elife.106811
BibTeX
@article{Kikawa2026,
author = {Kikawa, Caroline and Loes, Andrea N and Huddleston, John and Figgins, Marlin D and Steinberg, Philippa and Griffiths, Tachianna and Drapeau, Elizabeth M and Peck, Heidi and Barr, Ian and Englund, Janet A and Hensley, Scott E and Bedford, Trevor and Bloom, Jesse D},
title = {High-throughput neutralization measurements correlate strongly with evolutionary success of human influenza strains},
journal = {eLife},
year = {2026},
doi = {10.7554/elife.106811}
}
EUVIMED